Eric Pierce will join the Massachusetts Eye and Ear Infirmary at Harvard University in September as associate director of the Berman-Gund Laboratory for the Study of Retinal Degenerations and director of the Ocular Genomics Institute, where he will direct the genetic therapies program.
Pierce will work in close collaboration with Berman-Gund Laboratory director Eliot Berson and Janey Wiggs, who will direct the genetic diagnostics section of the Institute.
Pierce's scientific work has included using next-gen sequencing to identify retinal degeneration genes and to improve diagnostic testing. Since 2003 Pierce has been a member of the scientific advisory board of the Foundation Fighting Blindness, and has been its chair since 2005.
Previously, he was a faculty member at Children's Hospital Boston and a faculty member at the F.M. Kirby Center for Molecular Ophthalmology in the Scheie Eye Institute at the University of Pennsylvania School of Medicine.
He holds a PhD in biochemistry from the University of Wisconsin-Madison, and an MD from Harvard Medical School/MIT Health Sciences and Technology Division.
Glen Weiss will serve as the chief medical officer for an international lung cancer research consortium, the Cancer Research and Biostatistics-Clinical Trials Consortium.
Weiss is currently the co-head of the lung cancer unit and assistant professor at the Translational Genomics Research Institute, director of thoracic oncology at TGen Clinical Research Services at Scottsdale Healthcare, and holds a clinical assistant professor of medicine appointment at the University of Arizona College of Medicine-Phoenix. He is board certified in internal medicine and medical oncology, and his research focuses on genomic and microRNA characterization of lung cancer and early-detection strategies. He holds an MD from the Sackler School of Medicine in Tel Aviv.